LETROZOLE FARMOZ

Land: Israel

Sprog: engelsk

Kilde: Ministry of Health

Aktiv bestanddel:

LETROZOLE

Tilgængelig fra:

BIOAVENIR LTD, ISRAEL

ATC-kode:

L02BG04

Lægemiddelform:

FILM COATED TABLETS

Sammensætning:

LETROZOLE 2.5 MG

Indgivelsesvej:

PER OS

Recept type:

Required

Fremstillet af:

WEST PHARMA - PRODUCOES. DE ESPECIALIDADES FARMACEUTICA S.A., PORTUGAL

Terapeutisk gruppe:

LETROZOLE

Terapeutisk område:

LETROZOLE

Terapeutiske indikationer:

Letrozole Farmoz tablets is indicated for first-line treatment in postmenopausal women with hormone receptor positive or in whom hormone receptor status cannot be determined, locally advanced or metastatic breast cancer: Letrozole Farmoz is also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy. Extended adjuvant treatment of early breast cancer in post menopausal women who have received prior standard adjuvant tamoxifen therapy. Adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Autorisation dato:

2014-12-31